AlphaYou
Overview
We haven't scored this stock yet - the numbers below are real, just not machine-graded.
Key stats
Sep 1- Open
- $1,049.87
- 52-wk high
- $1,061.57
- High
- $1,053.00
- 52-wk low
- $661.85
- Low
- $1,018.60
- Prev close
- $1,058.90
- Mkt cap
- $63.63B
- P/E
- 38.9x
- Volume
- 175.5K
- Fwd P/E
- 37.6x
- Beta
- -0.04
- P/S
- 12.0x
- P/B
- 7.9x
- Profit margin
- +32.3%
- Op margin
- +32.0%
- ROE
- +23.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position.
What funds are doing
Earnings
Earnings came in 16.7% above what analysts expected.
Earnings per share
$6.27 expected
Reports Oct 22, 2026, in 51 days
EPS expected
$6.38 to $8.89
Revenue expected
19 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.13B | $3.21B | $1.30B | $2.82B |
| Cost of what it sold | $109.4M | $339.9M | $121.0M | $279.3M |
| Gross profit | $1.02B | $2.87B | $1.18B | $2.54B |
| What it spent | ||||
| Research and development | $355.7M | $443.0M | $443.0M | $486.0M |
| Sales and admin | $336.3M | $422.5M | $355.0M | $532.5M |
| Other operating costs | $85.0M | $1.15B | $106.0M | $671.1M |
| Total operating expenses | $777.0M | $2.01B | $904.0M | $1.69B |
| What was left | ||||
| Operating profit | $350.0M | $850.8M | $394.0M | $846.8M |
| Interest on debt | $993.0K | $1.0M | $1.0M | $2.0M |
| Profit before tax | $386.1M | $991.7M | $426.0M | $958.9M |
| Tax | — | -$55.0M | — | $119.1M |
| Net profit | $344.3M | $1.05B | $366.0M | $838.8M |
| EBITDA | — | $1.01B | — | $863.8M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Strong Argenx stock trades close to 52-week high as Q2 2026 profits beat expectations
BullishAug 26Strong Argenx stock holds close to 52-week high as downgrade follows earnings beat
Leans bullishAug 25Resilient argenx stock trades above €780 as biotech valuation climbs
NeutralAug 24argenx SE (ARGX) Won Its Phase 3 Myositis Trial. How Much Does the Subgroup Miss Matter?
Leans bullishAug 22Resilient Argenx stock holds above $1,030 as long term earnings forecasts rise
BullishAug 21Argenx stock trades above $1,030 as analysts lift long-term earnings outlook
BullishAug 20A Quick Look at Today's Ratings for Argenx SE(ARGX.US), With a Forecast Between $1,095 to $1,301
NeutralAug 20Argenx stock climbs after ALKIVIA data and analyst upgrades
BullishAug 20